News & Analysis as of

Private Equity Technology

Ropes & Gray LLP

Finding Alpha in Consumer

Ropes & Gray LLP on

As we move through 2025, the phrase “finding alpha” has become the mantra for private equity (PE) investors focused on the consumer sector. Confidence in the sector remains robust, but the narrative has shifted: it is no...more

DLA Piper

2025 Private Credit Technology Summit: Perspectives from the Industry

DLA Piper on

Technology’s role in private credit is expanding, with digital tools, data management, and artificial intelligence (AI) reshaping underwriting, portfolio monitoring, and reporting processes....more

Ropes & Gray LLP

Dealmaker's Digest: A Top 10 Bulletin - July 2025

Ropes & Gray LLP on

In Dealmaker’s Digest, read the top 10 latest developments in global transactions. We offer insights into M&A activity across industries and borders. The first half of 2025 saw a 13% increase in global deal value and 5%...more

MoFo Life Sciences

Key Developments in MedTech M&A: Momentum Despite Macroeconomic Uncertainty

MoFo Life Sciences on

2024 was a challenging year for M&A activity in the medical technology (“MedTech”) industry. Although some sectors experienced a rebound in deal volume, MedTech dealmakers were disproportionately affected by a difficult...more

Bennett Jones LLP

Private Equity and Venture Capital Investors Showing Renewed Interest in the Defence Industry

Bennett Jones LLP on

With NATO members recently agreeing to increase defence spending to levels unseen since the Second World War, this is a timely opportunity to take a closer look at a theme we have been hearing a lot about lately – the growing...more

Ropes & Gray LLP

Evolving Dynamics and Optimism; Our Forecasts for the Real Estate Market in 2025 for Private Capital

Ropes & Gray LLP on

In 2025, the real estate market for private capital will evolve considerably, driven by economic shifts, regulatory pressures, and advancements in technology. As a maturing debt landscape, rising demand for sustainable...more

Skadden, Arps, Slate, Meagher & Flom LLP

Europe’s Sharpened Focus on Defense Creates M&A and Investment Opportunities

Key Points - - The war in Ukraine has prompted a historic surge in European defense spending. - Governments in the EU and U.K. are stressing the need for innovation. They are increasingly turning to investment in small...more

Ankura

Where's My MOIC? Come Along on the Innovation Journey if You Dare

Ankura on

Let us cut to the chase: In the high-stakes world of middle-market enterprises, innovation is not a luxury—it is survival calculus. Your Multiple of Invested Capital (MOIC) is not just a number on a spreadsheet; it is the DNA...more

Ropes & Gray LLP

SuperReturn International 2025: Four Key Takeaways

Ropes & Gray LLP on

Ropes & Gray attended the SuperReturn International conference in Berlin last week, which attracted over 5,500 decision makers from the private markets industry who came together to share their outlook for 2025 and beyond....more

Fenwick & West LLP

Q1 2025 Venture Beacon: Key VC Market Trends

Fenwick & West LLP on

In this edition of the J.P. Morgan Venture Beacon, we analyze venture deals from Series Seed through Series D+ to surface the real-time dynamics shaping today’s startup ecosystem. Produced in collaboration with J.P. Morgan |...more

Skadden, Arps, Slate, Meagher & Flom LLP

Inside the Courts – May 2025

Key Points - - The SEC’s Crypto Task Force acknowledges past hostility toward digital assets and aims to create more sensible regulations. - Tokenized securities face complex regulatory challenges, including compliance...more

Bradley Arant Boult Cummings LLP

Paramount May Usher In a Big Change to Hollywood’s Ruling Class | Insights & Events

Family offices have long been part of Hollywood’s DNA, quietly shaping its most iconic moments and technological progress. Paramount Pictures was one of Hollywood’s first family-controlled studios under business titan Adolph...more

White & Case LLP

Life Science Private Equity Risk

White & Case LLP on

Private Equity focused on investment and operations within the Life Science industry faces significant compliance, operational and business risk due to the heavily regulated nature of the investment targets and portfolio...more

Ankura

Metrics That Matter Revisited: Elevate Your Playbook

Ankura on

Private Equity (PE) firms face pressure to deliver strong returns while managing downside risk. This necessitates a focus on performance metrics that measure value creation and overall health. However, the reporting shared by...more

Ankura

Investing in the Future: Private Equity and Corporate Strategies in American Childcare

Ankura on

The American childcare industry stands at a pivotal moment of transformation. The sector faces significant challenges including affordability concerns, staffing shortages, and operational inefficiencies. These challenges,...more

Knobbe Martens

Boston Scientific Agrees to Acquire Sonivie Ltd. For up to $540 Million

Knobbe Martens on

Boston Scientific recently announced it entered into a definitive agreement to acquire SoniVie Ltd. According to the press release, SoniVie is a privately held medical device company that developed the TIVUS Intravascular...more

Akin Gump Strauss Hauer & Feld LLP

2025 Perspectives in Private Equity: Cross-border Investment Review and New Restrictions

Navigating the complex landscape of foreign investment review is crucial for private equity (PE) firms operating in an international landscape. The Committee on Foreign Investment in the United States (CFIUS) continues to be...more

Morrison & Foerster LLP

M&A in 2024 and Trends for 2025

Global M&A in 2024 faced geopolitical issues, elevated interest rates, and inflationary pressures, with expanding antitrust, foreign investment, national security, and export regimes adding complexity. But inflation receded...more

Perkins Coie

Treasury’s Final Rule on Outbound Investments Takes Effect January 2

Perkins Coie on

On January 2, 2025, the U.S. Department of the Treasury’s (Treasury) regulation restricting U.S. outbound investments in certain advanced technology sectors in China (the Final Rule) takes effect. Thereafter, investments by...more

DarrowEverett LLP

Winning at M&A in 2025: The Insider’s Playbook

DarrowEverett LLP on

As an avid Red Sox fan and former Los Angeles resident who often attended Dodgers games, I may still be basking in the Yankees’ loss in the World Series. Whatever the reason, I can’t help but draw parallels between the game...more

Skadden, Arps, Slate, Meagher & Flom LLP

US Treasury Creates the ‘Reverse CFIUS’ Program, a (Limited) Great Wall on Outbound Investment

The Department of the Treasury (Treasury) has released a final rule imposing restrictions on U.S. outbound investment in Chinese companies active in developing certain national security technologies (Final Outbound Rule)....more

StoneTurn

NCSC Warns U.S. Startups and Investors of Foreign Bad Actors with Money to Spend

StoneTurn on

Last week, the National Counterintelligence and Security Center (“NCSC”), the Office of Economic Security and Emerging Technologies (“OESET”) and other coordinating government agencies issued a warning to U.S. venture...more

Benesch

Dental/DSO Intelligence Monthly Report: June/July 2024

Benesch on

A study at the University of Illinois Chicago College of Dentistry developed a chatbot using information reviewed by faculty members to answer questions about clinical procedures. Cortino Sukotjo, DDS, PhD, a professor of...more

McDermott Will & Emery

Key Takeaways | Clinical Trial Site Management Organizations (SMOs)

McDermott Will & Emery on

During this session, the panelists discussed the role that SMOs and dedicated clinical trial sites (Site Platforms) play within the life sciences industry, what makes them attractive to investors, and the key criteria...more

Skadden, Arps, Slate, Meagher & Flom LLP

One Step Closer to a Limited ‘Reverse CFIUS’ Program

On June 21, 2024, the U.S. Department of the Treasury announced a proposed rule (Proposed Rule) to impose limited restrictions on certain outbound U.S. investments in technology, as directed by Executive Order 14105....more

75 Results
 / 
View per page
Page: of 3

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide